A new review of the evidence finds that only a handful of common remedies provide a modest benefit for acute or chronic back ...
Contrary to popular belief, young adults can experience significant acute and even chronic pain—which can motivate them to ...
About four in five people will experience lower back pain at some point in their lives, with 80-90 per cent of back pain ...
Only around one in 10 common non-surgical and non-invasive treatments for lower back pain are effective, suggests a pooled ...
ACP released new clinical guidance on outpatient treatment of acute episodic migraine with combination therapy in patients who are not pregnant or lactating in outpatient settings.The two ...
Medication, physical therapy, steroid injections, and implanted devices may be helpful, but newer research has discovered ...
Neuroscientists have shown that experiencing nature can alleviate acute physical pain. Surprisingly, simply watching nature videos was enough to relieve pain. Using functional magnetic resonance ...
1 天
Pharmaceutical Technology on MSNLatigo secures $150m for non-opioid pain treatment developmentLatigo has secured $150m in a Series funding round, which will be used to further the development of its Nav1.8 inhibitors.
Terpenes from cannabis may relieve chronic pain without THC’s psychoactive effects. Researchers found that certain terpenes ...
Latigo Biotherapeutics has whipped together a $150 million series B fundraising round to advance a pipeline of non-opioid ...
Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ...
A recently completed study found that certain terpenes in Cannabis sativa are effective at relieving post-surgical and fibromyalgia pain in preclinical models.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果